TriPath Investment By Roche Boosts Stock 36% In August, Index Jumps 11%
This article was originally published in The Gray Sheet
Executive Summary
A $40 mil. investment in TriPath Imaging by pharmaceutical and diagnostics giant Roche was the driving force behind a 36.1% jump in TriPath's stock price in August. The issue gained 2-3/16 to close the month at 8-1/4.